Companies /Healthcare

Orthofix Medical Inc

NASDAQ: OFIX Medical Devices
$6.67
▼ $0.13 (−1.91%) today
Markets closed · 6:11pm ET

OFIX at a Glance

Valuation
Market cap
$277.2M
Profitability
Revenue (TTM)
$835.4M
Profit margin
-5.4%
EPS (TTM)
$-1.10
Price
52-week range
$7 – $16
Street target
$10.00

Headquartered in Lewisville, TX Fiscal year ends December NASDAQ: OFIX orthofix.com

About Orthofix Medical

Orthofix Medical Inc. (NASDAQ: OFIX) is a global medical technology company focused on musculoskeletal care. It sells spinal implants, therapeutic solutions (bone growth stimulation, formerly Bone Growth Therapies), limb reconstruction systems, biologics and enabling technologies. The company reports through Global Spine (Therapeutic Solutions plus Spinal Implants, Biologics and Enabling Technologies) and Global Limb Reconstruction segments.

Key products by area:
- Spinal implants: VIRATA, NorthStar OCT, Mariner, WaveForm and Reef.
- Bone growth stimulators: AccelStim, SpinalStim, PhysioStim and CervicalStim, using PEMF technology.
- Biologics: Trinity Elite, OsteoStrand Plus, OsteoCove and OsteoBallast.
- Limb reconstruction: FITBONE, TRUELOK Elevate, TL-HEX and Galaxy Gemini.
- Enabling technologies: the 7D FLASH Navigation System, a radiation-free, machine-vision image-guided spine surgery system, placed through capital purchase, lease or the Voyager earnout program that ties placements to recurring implant and biologics purchases.

The company sells largely through distributor networks, with U.S. Spine accounting for most of spine revenue. It targets an addressable market of roughly $16 billion. It is currently restructuring its U.S. Spine distribution and instrument-set deployment and has discontinued its M6 product lines. It also continues to integrate its prior merger with SeaSpine. Updated

Latest Activity

OFIXOrthofix Medical
Q3 2026
EPS
-$0.15
est $0.11-$0.26
Revenue
$208M
est $211M-1.3%

A loss where analysts modeled a profit is the swing that matters for a $318 million market cap. Orthofix cut full-year sales guidance to $825 million to $830 million from $845 million to $855 million after U.S. Spine revenue fell on supplier delays and instrument-set shortages. Resources are shifting to top distributors before the Q4 VIRATA launch.

Quarterly EPS — reported vs estimate

OFIX Coverage

Frequently Asked Questions

What does Orthofix Medical do?

Orthofix Medical Inc. (NASDAQ: OFIX) is a global medical technology company focused on musculoskeletal care. It sells spinal implants, therapeutic solutions (bone growth stimulation, formerly Bone Growth Therapies), limb reconstruction systems, biologics and enabling technologies.

What is the OFIX stock price target?

The Wall Street consensus 12-month price target for OFIX is $10.00.